Stealthy robotics-company Auris Surgical Robotics, led by Intuitive Surgical founder Dr. Frederic Moll, raised $150 million in a new round of equity financing, according to an SEC filing posted today.
Redwood City, Calif.-based Auris is developing a surgical robot for ophthalmological procedures, but has not released any details surrounding the device.
Funds came from 25 unnamed investors, according to the SEC filing, but Auris has not revealed any information about what the funds will be used for.
Previous investors included Ajay Royan of Mithril Capital Management, Robert Higgins of Highland Capital Partners, Peter Hébert of Lux Capital and Dr. Bijan Salehizadeh of the NaviMed Capital, according to a filing.
Last April, Auris Surgical said it raised more than $34 million in an equity round. Auris did not reveal the names of the 20 backers who joined the $34.4 million round, but the company is led by Moll.
Moll is the serial entrepreneur behind a raft of robotic surgery companies including Intuitive, Hansen Medical (NSDQ:HNSN), Mako Surgical and Restoration Robotics.
In October 2013, Auris and Biolase (NSDQ:BIOL) inked a deal to collaborate on developing the cataract-removal ophthalmologic robot, using Biolase’s WaterLase cutting technology to create a prototype.